The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

VIVUS Inc

Nasdaq: VVUS
Last

(U.S.) $1.18

Today's change-0.01 -0.84%
Updated January 18 10:18 AM EST. Delayed by at least 15 minutes.
 

VIVUS Inc

Nasdaq: VVUS
Last

(U.S.) $1.18

Today's change-0.01 -0.84%
Updated January 18 10:18 AM EST. Delayed by at least 15 minutes.

VIVUS Inc down (U.S.)$0.01

VIVUS Inc is lower today, dropping (U.S.)$0.01 or 0.84% to (U.S.)$1.18. Shares have lost 2.48% for the last five days, but have gained 13.46% over the last 52 weeks. This security has underperformed the S&P 500 by 7.26% during the last year.

Key company metrics

  • Open(U.S.) $1.19
  • Previous close(U.S.) $1.19
  • High(U.S.) $1.19
  • Low(U.S.) $1.16
  • Bid / Ask(U.S.) $1.17 / (U.S.) $1.18
  • YTD % change+2.61%
  • Volume32,770
  • Average volume (10-day)362,175
  • Average volume (1-month)481,784
  • Average volume (3-month)475,397
  • 52-week range(U.S.) $0.92 to (U.S.) $1.85
  • Beta1.27
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.44
Updated January 18 10:18 AM EST. Delayed by at least 15 minutes.
S&P TSX0.42%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue13141515
Total other revenue--------
Total revenue13141515
Gross profit11111213
Total cost of revenue2343
Total operating expense14172020
Selling / general / administrative10141514
Research & development2113
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--0--0
Other operating expenses, total--------
Operating income-1-4-5-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-9-11-13-12
Income after tax-9-11-13-12
Income tax, total0000
Net income-9-11-13-12
Total adjustments to net income--------
Net income before extra. items-9-11-13-12
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-9-11-13-12
Inc. avail. to common incl. extra. items-9-11-13-12
Diluted net income-9-11-13-12
Dilution adjustment--0----
Diluted weighted average shares104104104104
Diluted EPS excluding extraordinary itemsvalue per share-0.09-0.11-0.12-0.12
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.09-0.11-0.12-0.12